SCO Securities

SCO Securities was a boutique investment bank and private equity firm that specialized in the life sciences and healthcare sectors. As the broker-dealer subsidiary of SCO Financial Group, the firm provided strategic advisory, capital raising, and restructuring services to emerging biotechnology and medical technology companies. SCO was recognized for its 'active value' investment strategy, which involved taking significant positions in undervalued healthcare entities and providing hands-on management to drive clinical development and shareholder value. The firm played a key role in the financing and governance of numerous micro-cap life science organizations, including Access Pharmaceuticals and Vical. While the firm was a prominent financier in the biotech space during the 2000s, its broker-dealer operations are no longer active. Its legacy is defined by its activist approach to healthcare investing and its focus on distressed or overlooked clinical assets.